Marburg, Germany

Klaus-Jurgen Steffens


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Klaus-Jurgen Steffens: Innovator in Pharmaceutical Formulations

Introduction

Klaus-Jurgen Steffens is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of parenteral medications. His innovative approach has led to advancements in the delivery of sparingly soluble substances.

Latest Patents

Steffens holds a patent for a pharmaceutical formulation and process for its preparation. This patent describes a method for creating a pharmaceutical formulation suitable for intravenous administration. The formulation involves dispersing very finely ground substances, with a maximum particle diameter of 3 µm, in an oil phase containing emulsifiers. This mixture is then emulsified with water for injection, rendered isotonic, and homogenized using a high-pressure homogenizer. The result is a solid/liquid/liquid disperse system that enhances the delivery of challenging pharmaceutical compounds.

Career Highlights

Klaus-Jurgen Steffens has had a distinguished career, working at Behringwerke Aktiengesellschaft, a company known for its contributions to biopharmaceuticals. His work has focused on improving drug formulations to ensure better patient outcomes. His innovative spirit and dedication to research have positioned him as a key figure in his field.

Collaborations

Throughout his career, Steffens has collaborated with esteemed colleagues, including Paul H List and Peter C Schmidt. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical technology.

Conclusion

Klaus-Jurgen Steffens is a prominent inventor whose work in pharmaceutical formulations has made a lasting impact on the industry. His innovative approaches continue to influence the development of effective drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…